Alik Farber, MD
Professor, Surgery
Biography
Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
Other Positions
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University Chobanian & Avedisian School of Medicine
- Professor, Vascular & Interventional, Radiology, Boston University Chobanian & Avedisian School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
Education
- Harvard Medical School, MD
- Brown University, BS
Publications
- Published on 9/22/2023
Levin SR, Alonso A, Salazar ED, Farber A, Chitalia VC, King EG, Cheng TW, Siracuse JJ. Recent Evaluation by Nephrologists is Associated with Fewer Tunneled Dialysis Catheter Being Used at the Time of First Arteriovenous Access Creation. J Vasc Surg. 2023 Sep 22. PMID: 37742733.
Read at: PubMed - Published on 8/4/2023
Levin SR, Farber A, Goodney PP, King EG, Eslami MH, Malas MB, Patel VI, Kiang SC, Siracuse JJ. Five Year Survival in Medicare Patients Undergoing Interventions for Peripheral Arterial Disease: a Retrospective Cohort Analysis of Linked Registry Claims Data. Eur J Vasc Endovasc Surg. 2023 Oct; 66(4):541-549. PMID: 37543356.
Read at: PubMed - Published on 7/30/2023
Dillavou E, Lucas JF, Woodside K, Burgess J, Farber A, Hentschel D, Ozaki CK. VasQ U.S. pivotal study demonstrates the safety and effectiveness of an external vascular support for arteriovenous fistula creation. J Vasc Surg. 2023 Jul 30. PMID: 37527689.
Read at: PubMed - Published on 7/19/2023
Levin SR, Farber A, King EG, Perry AG, Cheng TW, Siracuse JJ. Functional Impairment is Associated with Poor Long-Term Outcomes after Arteriovenous Access Creation. Ann Vasc Surg. 2023 Jul 19. PMID: 37479179.
Read at: PubMed - Published on 6/17/2023
Idrees N, Haroon S, Zhang Y, Mangio JC, Siracuse JJ, Francis JM, Ganguli S, Daly K, Diamond M, Vilvendhan R, Cabral H, Dember LM, Farber A, Kolachalama VB, Chitalia VC. Contrast Venography Versus Intravenous Ultrasound in Hemodialysis Arteriovenous Access Dysfunction. Kidney Int Rep. 2023 Sep; 8(9):1887-1891. PMID: 37705907.
Read at: PubMed - Published on 6/16/2023
Zhu M, Mota L, Farber A, Schermerhorn ML, King E, Alonso A, Kobzeva-Herzog A, Morrissey N, Malas M, Siracuse JJ. The impact of neighborhood social disadvantage on presentation and management of first-time hemodialysis access surgery patients. J Vasc Surg. 2023 Oct; 78(4):1041-1047.e1. PMID: 37331447.
Read at: PubMed - Published on 6/14/2023
Siracuse JJ, Farber A, Menard MT, Conte MS, Kaufman JA, Jaff M, Kiang SC, Ochoa Chaar CI, Osborne N, Singh N, Tan TW, Guzman RJ, Strong MB, Hamza TH, Doros G, Rosenfield K. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial. J Vasc Surg. 2023 Oct; 78(4):1012-1020.e2. PMID: 37318428.
Read at: PubMed - Published on 5/26/2023
Cheng TW, Farber A, Levin SR, Arinze N, Garg K, Eslami MH, King EG, Patel VI, Rybin D, Siracuse JJ. Analysis of Early Death after Elective Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2023 Oct; 96:71-80. PMID: 37244479.
Read at: PubMed - Published on 5/17/2023
Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I. Baseline modern medical management in the BEST-CLI trial. J Vasc Surg. 2023 Sep; 78(3):711-718.e5. PMID: 37201761.
Read at: PubMed - Published on 5/12/2023
Plauche L, Farber A, King EG, Levin SR, Cheng TW, Rybin D, Siracuse JJ. Brachiocephalic and Radiocephalic Arteriovenous Fistulas in Patients with Tunneled Dialysis Catheters Have Similar Outcomes. Ann Vasc Surg. 2023 Oct; 96:98-103. PMID: 37178905.
Read at: PubMed
View 330 more publications: View full profile at BUMC